IL10 and juvenile idiopathic arthritis: An increase of IL-10 in the active stage of the disease suggests that the anti-inflammatory effects may be reduced during systemic flares [38, 40], or alternatively, that remarkable upregulation of genes associated with IL-10 signaling in recent onset occurs in untreated JIA patients [41].